Immortalized mammary epithelial cells overexpressing protein kinase C gamma acquire a malignant phenotype and become tumorigenic in vivo.

We have investigated the role of a classical isoform of protein kinase C (PKCgamma) in promoting immortalized mammary cell tumorigenesis in vivo and the contribution of proteases and adhesion molecules to this process. We hypothesized that overexpression of PKCgamma in immortalized mammary epithelial cells may initiate, by activating the mitogenic ERK pathway, early changes in proteases, adhesion molecules, and markers of an epithelium-to-mesenchyme transition that may contribute to in vivo tumorigenesis. Here we show that compared to vector-transfected cells, immortalized murine mammary epithelial cells (NMuMG) overexpressing PKCgamma have stronger activation of (approximately 5-fold) ERK1/2 MAPKs, which results in a similar increase in cyclin D1. In addition, PKCgamma-expressing cells showed increased levels of vimentin, fibronectin (FN), beta1-integrins, enhanced adhesion to fibronectin, and its organization into fibrils. Concomitantly, PKCgamma induced a dramatic down-regulation of E-cadherin protein levels and its localization to cell-cell junctions. NMuMG cells expressing PKCgamma became resistant to death by anoikis and formed colonies in soft agar. This effect was dependent on ERK activation, because Mek1/2 inhibition with PD98059 abrogated anchorage-independent growth. Most importantly, unlike control NMuMG cells, PKCgamma-transfected cells inoculated s.c. into nude mice displayed tumorigenic and invasive capacity and were able to spontaneously metastasize. This behavior correlated with increased production of uPA and MMPs-9/-2 induced by PKCgamma. These results suggest that PKCgamma overexpression in immortalized mammary epithelial cells may generate, through an increase in ERK, signaling changes in the expression of genes associated with an epithelium-to-mesenchyme transition that may be sufficient to favor tumor growth in vivo.

[1]  Yusuf A. Hannun,et al.  Regulation of protein kinase C and role in cancer biology , 1994, Cancer and Metastasis Reviews.

[2]  J. Aguirre-Ghiso,et al.  Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. , 2001, Molecular biology of the cell.

[3]  D. Wheeler,et al.  Protein Kinase C-ε Transgenic Mice: A Unique Model for Metastatic Squamous Cell Carcinoma , 2001 .

[4]  H. Moon,et al.  Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. , 2001, Cancer research.

[5]  H. Moses,et al.  Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. , 2001, The Journal of biological chemistry.

[6]  D. Wheeler,et al.  Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. , 2001, Cancer research.

[7]  John N. Hutchinson,et al.  Transgenic mouse models of human breast cancer , 2000, Oncogene.

[8]  H. Moses,et al.  Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.

[9]  G. Hunninghake,et al.  Protein Kinase C ζ Plays a Central Role in Activation of the p42/44 Mitogen-Activated Protein Kinase by Endotoxin in Alveolar Macrophages1 , 2000, The Journal of Immunology.

[10]  V. Jordan,et al.  Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines , 2000, British Journal of Cancer.

[11]  M J Bissell,et al.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. , 2000, Endocrine-related cancer.

[12]  S. Hoffman,et al.  Thrombin upregulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C-gamma activation. , 2000, American journal of respiratory cell and molecular biology.

[13]  J. Thiery,et al.  Development of mammary gland requires normal beta 1-integrin function. , 2000, Advances in experimental medicine and biology.

[14]  S. Kiley,et al.  Increased protein kinase Cδ in mammary tumor cells: relationship to transformation and metastatic progression , 1999, Oncogene.

[15]  L. Ossowski,et al.  Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling , 1999, The Journal of cell biology.

[16]  J. Schwarzbauer,et al.  Fibronectin fibrillogenesis: a paradigm for extracellular matrix assembly. , 1999, Current opinion in cell biology.

[17]  M. Kazanietz,et al.  New insights into the regulation of protein kinase C and novel phorbol ester receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Zhimin Lu,et al.  RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases , 1999, Oncogene.

[19]  D. Gomez,et al.  Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. , 1999, European journal of biochemistry.

[20]  G. Verstovsek,et al.  Alterations in the expression and localization of protein kinase C isoforms during mammary gland differentiation. , 1999, European journal of cell biology.

[21]  J. Westermarck,et al.  Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  J. Brugge,et al.  Protein Kinase C Regulates Integrin-induced Activation of the Extracellular Regulated Kinase Pathway Upstream of Shc* , 1999, The Journal of Biological Chemistry.

[23]  K. Rodland,et al.  Regulation of proliferation and apoptosis by epidermal growth factor and protein kinase C in human ovarian surface epithelial cells. , 1999, Experimental cell research.

[24]  E Ruoslahti,et al.  Integrin signaling. , 1999, Science.

[25]  Z. Werb,et al.  ECM signalling: orchestrating cell behaviour and misbehaviour. , 1998, Trends in cell biology.

[26]  Erkki Ruoslahti,et al.  Fibronectin Matrix Regulates Activation of RHO and CDC42 GTPases and Cell Cycle Progression , 1998, The Journal of cell biology.

[27]  M. Pfaff,et al.  Integrin affinity modulation. , 1998, Trends in cell biology.

[28]  M J Bissell,et al.  Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. , 1998, The American journal of pathology.

[29]  D. Rose,et al.  Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype. , 1998, International journal of oncology.

[30]  P. Herrlich,et al.  Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. , 1998, Genes & development.

[31]  M. Duffy,et al.  The urokinase‐type plasminogen activator system in cancer metastasis: A review , 1997, International journal of cancer.

[32]  D. Alonso,et al.  A phospholipase D and protein kinase C inhibitor blocks the spreading of murine mammary adenocarcinoma cells altering f‐actin and β1‐integrin point contact distribution , 1997, International journal of cancer.

[33]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[34]  Jussi Taipale,et al.  Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  M. Poyard,et al.  Protein kinase C isoform expression in normal and failing rabbit hearts. , 1996, Circulation research.

[36]  N. Rahimi,et al.  Fibronectin fibrils and growth factors stimulate anchorage-independent growth of a murine mammary carcinoma. , 1996, Experimental cell research.

[37]  John Calvin Reed,et al.  The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Z. Werb,et al.  Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1. , 1995, Seminars in cancer biology.

[39]  P. Parker,et al.  MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. , 1995, The Journal of clinical investigation.

[40]  N. Oliver,et al.  Transcriptional repression of fibronectin gene expression in v-src transformation. , 1995, Experimental Cell Research.

[41]  J. Bos,et al.  Regulation of Ras-mediated signalling: more than one way to skin a cat. , 1995, Trends in biochemical sciences.

[42]  M. Cheever,et al.  Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo. , 1994, Journal of Immunology.

[43]  S. Bourgeois,et al.  A novel mechanism of Ha-ras oncogene action: regulation of fibronectin mRNA levels by a nuclear posttranscriptional event , 1994, Molecular and cellular biology.

[44]  W. Wetsel,et al.  Tissue and cellular distribution of the extended family of protein kinase C isoenzymes , 1992, The Journal of cell biology.

[45]  Michael C. Ostrowski,et al.  Protein kinase C gamma expression mimics phorbol ester-induced transcriptional activation of a murine VL30 enhancer element. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[46]  W. Wilkison,et al.  Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA , 1988, Cell.

[47]  L. Ossowski,et al.  Antibodies to plasminogen activator inhibit human tumor metastasis , 1983, Cell.

[48]  L. Ossowski,et al.  Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue , 1979, Cell.

[49]  R B Owens,et al.  Glandular epithelial cells from mice: a method for selective cultivation. , 1974, Journal of the National Cancer Institute.